|
Volume 271, Number 47,
Issue of November 22, 1996
pp. 30034-30040
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Interaction of Transducin with Light-activated Rhodopsin Protects
It from Proteolytic Digestion by Trypsin*
(Received for publication, August 9, 1996, and in revised form, September 9, 1996)
Maria R.
Mazzoni
§ and
Heidi E.
Hamm
¶
From Istituto Policattedra di Discipline Biologiche,
University of Pisa, 56126 Pisa, Italy and the ¶ Department of
Physiology and Biophysics, University of Illinois at Chicago,
Chicago, Illinois 60612
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
The tryptic cleavage pattern of transducin
(Gt) in solution was compared with that in the presence of
phospholipid vesicles, rod outer segment (ROS) membranes kept in the
dark, or ROS membranes containing light-activated rhodopsin,
metarhodopsin II (Rh*). When Gt was in the high affinity
complex with Rh*, the t subunit was almost completely
protected from proteolysis. The protection of t at
Arg310 was complete, while Arg204 was
substantially protected. The cleavage of t at
Lys18 was protected in the presence of phospholipid
vesicles, ROS membranes kept in the dark, or ROS membranes containing
Rh*. The cleavage of t was slower in the presence of ROS
membranes or phospholipid vesicles. When the Rh*·Gt
complex was incubated with guanyl-5 -yl thiophosphate, a guanine
nucleotide analog known to release the high affinity interaction
between Gt and Rh*, the protection at Arg310
and Arg204 was diminished. From our results, we propose
that Rh* either physically blocks access of trypsin to
Arg204 and Arg310 or maintains the heterotrimer
in such a conformation that these cleavage sites are not available.
Since Arg204 is involved in the switch interface with
 t (Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 311-319), it may be that  t is implicated in
protecting this cleavage site in the receptor-bound, stabilized heterotrimer. Arg310 is not near the  t
subunit, thus we believe that the high affinity binding of
Gt to Rh* physically or sterically blocks access of trypsin
to this site. Thus, Arg310, only a few angstroms away from
the carboxyl terminus of t, which is known to directly
bind to Rh*, is likely to also be a part of the Rh* binding site. This
is in agreement with other studies and has implications for the
mechanism by which receptors catalyze GDP release from G proteins. The
protection of Lys18 in the presence of phospholipid
vesicles suggests that the amino-terminal region is in contact with the
membrane, consistent with the crystal structure of the heterotrimer
(Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and
Sigler, P. B. (1996) Nature 379, 311-319).
INTRODUCTION
Certain extracellular signals, including hormones,
neurotransmitters, neuromodulators, chemokines, odorants, and light,
activate a class of receptors that initiate cellular effects via
activation of heterotrimeric G proteins. Agonist binding to the G
protein-coupled receptors leads to conformational changes that promote
a tighter interaction with specific G proteins, catalysis of GDP
release, and subsequent G protein activation. In the absence of guanine nucleotides, agonist binding to the receptor is stabilized by the bound
G protein. The structural basis of the ternary complex among agonist,
receptor, and heterotrimeric G protein is an active area of study.
Extensive mutagenesis experiments, as well as peptide competition
investigations for a variety of G protein-coupled receptors, have led
to an understanding that the second and third cytoplasmic loops and, in
some circumstances, the putative fourth loop, as well as portions of
helices VI and VII, are important in recognition of cognate G
proteins (1, 2, 3). It has been shown that the heterotrimeric G protein,
rather than just the or  subunits, is required for the
interaction, but studies pointing out the importance of specific
regions are thus far limited to the subunits (4, 5, 6, 7).
The crystal structures of the active
(GTP S1 and GDP
AlF4 -bound) (8, 9, 10) and inactive
(GDP-bound) (11, 12) forms of the subunits of transducin
(Gt) and Gi1 have been reported. Analysis of
the two crystal forms has established the nature of the conformational
change induced by the exchange of GTP for GDP and the switch mechanism
by which the presence or absence of the -phosphate defines the
active or inactive state of the t subunit (9, 11). The
high resolution crystal structures of the heterotrimeric G proteins,
Gt and Gi1, provide a fundamental context for
understanding how a heterotrimer interacts with the membrane and with
activated receptors (13, 14). The molecular mechanisms involved in the conformational changes of the subunit and the nucleotide exchange induced by the heterotrimeric G protein interacting with activated receptors are of great interest. Denker et al. (15)
suggested that agonist binding to the receptor initiates the exchange
of nucleotide from Go by movement of the o
subunit carboxyl-terminal region. The guanine ring of GDP interacts
with the residues TCAT, 30 residues from the carboxyl terminus, in a
loop at the amino terminus of the final -helix ( 5). The
receptor-stimulated movement of -helix 5 may allow for the release
of GDP. Consistent with this suggestion, disturbing the interactions
between the conserved TCAT region of the subunit and the guanine
ring of GDP has been shown to decrease GDP affinity (16, 17).
It has been known for many years that the presence of G proteins
increases agonist affinity to receptors, while binding of either GDP or
GTP to the G protein complex disrupts the high affinity agonist binding
state (18, 19). Thus, one of the primary ways of measuring the ternary
complex formed by the agonist, receptor, and G protein, is by analyzing
the agonist affinity for the receptor. G protein binding to the
light-activated rhodopsin (Rh) receptor induces a high affinity state
that can be measured either as decreased ability to remove the G
protein from the membrane (20) or as stabilization of the active
signaling state of rhodopsin, metarhodopsin II (Rh*) (21, 22). The high
affinity state is induced by Rh*-catalyzed loss of GDP, leading to an
empty guanine nucleotide binding pocket (23). The addition of either
GTP or GDP can promote the loss of the high affinity state, measured by
centrifugation (20, 24, 25) or decay of Rh* (23, 26, 27). The
mechanisms involved in initiating the allosteric modulation of the
agonist binding site on the receptor upon guanine nucleotide binding to the G protein are still unknown.
The studies presented here investigate the following areas: 1)
determining the regions on Gt, besides those already
implicated, involved in its high affinity interaction with Rh*; 2)
elucidation of the conformational changes of Gt induced by
the tight interaction with Rh*; and 3) resolving how the conformational
changes induced by guanine nucleotide binding to the subunit
decrease the affinity of Gt for Rh* and cause Rh* decay.
The tryptic digestion pattern of Gt is well known (28, 29).
The GTP-induced conformational switch leads to a changed proteolytic
digestion at Arg204, in -helix 2 (28, 30). A proteolytic
site at the amino terminus of the t subunit is partially
protected by the presence of the  t subunit (31). In
this work, we examine whether the high affinity interaction between
Gt and activated rhodopsin (Rh*) affects the
t and t subunit proteolytic digestion
pattern. The effects of phospholipid vesicles (PL), rod outer segment
(ROS) membranes kept in the dark, or ROS membranes containing Rh* on tryptic digestion patterns of Gt were investigated. In
particular, we focused on the changes in the tryptic digestion pattern
and time course of the t subunit induced by Rh*
interaction. Our results indicate that the presence of ROS membranes
containing Rh, Rh*, or phospholipid vesicles each uniquely affects
Gt proteolysis but that interaction with Rh* has the most
dramatic effects.
EXPERIMENTAL PROCEDURES
Materials
TPCK-treated trypsin was purchased from
Worthington. GDP S and TLCK were products of Boehringer Mannheim. The
LumiGLO substrate kit and peroxidase-labeled antibodies to rabbit or
mouse IgG were purchased from Kirkegaard and Perry Laboratories, Inc.
Fluorescent and standard molecular weight markers were obtained from
Sigma. All other chemicals and reagents were of the
highest purity available.
Antibodies
Monoclonal antibody 4A was prepared and purified
as described by Hamm and Bownds (32) and Witt et al. (33).
The subunit antisera 116, 1398, and 8645 were a generous gift of
Dr. D. Manning (Department of Pharmacology, University of Pennsylvania,
Philadelphia) (34, 35). Antiserum 116 recognizes the synthetic peptide
IKNNLKDCGLF, which corresponds to i1/2-(344-354). This
antiserum also recognizes the t subunit (35). Antiserum
1398 recognizes t-(36-47) (GAGESGKSTIVK). Antiserum
8645 recognizes the synthetic peptide FDVGGQRSERKK, which corresponds
to t-(195-206).
Western Blotting
SDS-polyacrylamide gel (12.5%)
electrophoresis was carried out according to the method of Laemmli
(36). Proteins and peptides were electroblotted from the
SDS-polyacrylamide gel to nitrocellulose (0.1 µm, Schleicher & Schuell) essentially as described by Towbin et al. (37).
After an overnight transfer, the nitrocellulose was examined under UV
light to detect the fluorescent molecular weight markers. The
nitrocellulose was then incubated in PBS (10 mM
NaH2PO4, pH 7.4, 0.9% NaCl), containing 3%
lowfat dried milk and 0.2% Tween 20 (PBS/milk) at room temperature.
After 30 min, the nitrocellulose was incubated in PBS/milk buffer
containing monoclonal antibody 4A (50 µg/ml) or an
anti- t antiserum (1:8,000 dilution) for 1 h at room
temperature. The immunoblots were washed four times (10 min each) with
PBS/milk buffer and incubated in PBS/milk buffer containing
peroxidase-labeled second antibody (1:10,000 dilution) for 1 h at
room temperature. The washing step was repeated as described above,
followed by two washes with PBS and one with distilled water. The
immunoblots were incubated in LumiGLO substrate for 1 min at room
temperature in the light and then exposed to Kodak XAR-2 film for a few
seconds.
For some experiments, the immunoblots were stripped by incubation in
stripping buffer (62 mM Tris-HCl, pH 6.5, 100 mM -mercaptoethanol, 2% SDS) for 30 min at 50 °C,
followed by several washes with PBS.
Phospholipid Vesicles, ROS Membranes, and
Gt
Neutral phosphatidylcholine (PC) vesicles were a
generous gift of Dr. J. Malinski (Department of Biochemistry, Baylor
College of Medicine, Houston). PC vesicles were prepared essentially as described by Kim et al. (38) and resuspended in buffer A (10 mM MOPS, pH 7.5, 200 mM NaCl, 2 mM
MgCl2) containing 0.1 mM EDTA. The phospholipid
concentration was determined as described (39). In the final vesicle
preparation, the total phospholipid concentration was 4.9 mM, which corresponded to that present in ROS membranes containing 82 µM rhodopsin.
Bovine ROS membranes were prepared as described previously (29). ROS
membranes stripped with 4 M urea (urea-washed ROS
membranes) were prepared as described (40). Aliquots of both ROS
membrane preparations were stored in the dark at 80 °C until
needed. Rhodopsin concentration was determined by measuring the
absorbance of solubilized ROS membrane suspensions at 500 nm before and
after bleaching. Gt was extracted from ROS membranes as
described previously (29) and stored in 40% glycerol at 20 °C.
Gt concentration was determined by the Coomassie Blue
binding method (41), using bovine serum albumin as a standard
(Pierce).
Proteolysis of Gt
Limited tryptic digestion of
Gt in the absence and presence of urea-washed ROS membranes
kept in the dark, containing Rh* or PL, was performed essentially as
described by Mazzoni et al. (29). Gt was
incubated in buffer A (10 mM MOPS, pH 7.5, 200 mM NaCl, 2 mM MgCl2, 1 mM dithiothreitol) with urea-washed ROS membranes either in
the dark or light for 10 min at room temperature. The rhodopsin
concentration was 36 µM, while the
Gt:rhodopsin molar ratio was 1:5. For some experiments
performed in ambient light, 100 µM GDP S was present in
the buffer throughout the assay. All of the manipulations of samples
containing urea-washed ROS membranes kept in the dark were performed
under dim red light. After incubation, samples were centrifuged at
13,000 × g for 5 min at room temperature.
Gt (0.55 mg/ml) was similarly incubated in buffer A with PL
(2.2 mM PC). The samples containing ROS membranes or PL
were centrifuged at 50,000 rpm for 30 min at 4 °C in a Beckman fixed
angle TL-100.2 ultracentrifuge rotor. Pellets were resuspended in
buffer A containing 25% glycerol at a Gt concentration of
1.6 mg/ml and kept in ice. After removing an aliquot for the control at
time 0, trypsin solution (0.06 mg/ml in buffer A containing 25%
glycerol) was added. The final concentration of Gt was 0.8 mg/ml, and the trypsin:Gt (w/w) ratio was 1:25. As a
control, Gt was subjected to identical treatment in the
absence of urea-washed ROS membranes. The reaction was terminated by
incubating an aliquot of the reaction mixture with TLCK at a final
concentration of 40 µg/ml. After 5 min, 2 × electrophoresis sample buffer (37) was added, and the samples were immediately frozen
and stored at 80 °C. Proteolytic fragments were separated by
SDS-polyacrylamide (12.5%) gel electrophoresis as described above.
Data Analysis
For both Coomassie Blue-stained gels and
immunoblots, the density of polypeptide bands was measured using a
Molecular Dynamic densitometer (Personal Densitometer SI). Curve
fitting of the data was performed with nonlinear least square criteria
using GraphPad Prism software.
RESULTS
The recent determination of the high resolution crystal structure
of the heterotrimeric G protein, Gt, provided some
indication of the orientation of the molecule with respect to the
membrane and the visual receptor rhodopsin. To further understand the
structural basis of the high affinity interaction between rhodopsin and
Gt we determined the effect of the rhodopsin-Gt
complex formation on the accessibility of tryptic cleavage sites on the
t and t subunits.
The sequential appearance of proteolytic fragments during the time
course of Gt-limited tryptic digestion has been widely studied, and the origin of these fragments is well characterized (28, 29, 30) (Fig. 1). As indicated, the t
subunit has three regions that are readily available for limited
tryptic digestion: Lys18, Arg204, and
Arg310. Five transient proteolytic fragments of the
t subunit appear ( 38, 34,
32, 23, and 15), while the
final fragments are 21, 12,
5, and 2 (29). The t
subunit is rapidly converted to two stable fragments ( 23
and 14) (Fig. 1), while the t subunit remains intact (28). Under nondenaturing conditions, the two tryptic
fragments of the t subunit and the t
subunit remain tightly associated (28).
Fig. 1.
Distribution of proteolytic fragments from
the t and t subunits. The
dashed lines represent the cleavage sites available during
the limited tryptic digestion of t·GDP and
t. The number that follows or indicates the size of the fragment in kilodaltons.
[View Larger Version of this Image (35K GIF file)]
Purified Gt was incubated with PL, ROS membranes containing
inactive (Rh), or light-activated rhodopsin (Rh*), and after
centrifugation to remove any soluble Gt the membrane
fractions were incubated with trypsin. The rate of cleavage was
followed for 2 h. Potentially, interaction of Gt with
membranes or Rh* could either protect or increase accessibility of
known cleavage sites or expose new cleavage sites.
The time course of limited digestion of Gt in the presence
and absence of urea-washed ROS membranes is shown in Fig.
2. When soluble Gt was digested with
trypsin, the sequential appearance of proteolytic fragments that
migrated in the Coomassie Blue-stained polyacrylamide gels with
apparent molecular weights of 38, 34, 32, 23, 21, 14, and 12 kDa was
evident (Fig. 2A). According to our previous study (29)
(Fig. 1) these peptide bands corresponded to five t
( 38, 34, 32,
21, and 12) and two t
fragments ( 23 and 14) A dramatically
different result was obtained when Gt was incubated with
ROS membranes containing Rh* and allowed to form a high affinity
complex. In this complex, the t subunit remained
relatively uncleaved during the 2 h of digestion time course (Fig.
2B). To determine whether this protection occurred specifically because of the high affinity interaction with Rh*, parallel experiments were performed using Gt bound to ROS
membranes kept in the dark (Fig. 2D) or Gt-Rh*
incubated with GDP S, which dissociates the high affinity complex
(26, 27) (Fig. 2C). When Gt was in the presence
of inactive Rh, the time course of tryptic digestion of
t was much more similar to that observed for soluble
Gt, while in the presence of Rh* and GDP S, the tryptic pattern was intermediate. Since rhodopsin was also partially cleaved by
trypsin, the proteolytic digestion pattern of the t
subunit was difficult to analyze in the Coomassie Blue-stained gels due to the presence of numerous peptide bands (Fig. 2) (see below).
Fig. 2.
Time course of Gt limited tryptic
digestion in the presence and absence of ROS membranes containing Rh,
Rh*, or Rh* plus GDP S. Purified bovine Gt (0.54 mg)
was incubated in 1 ml of buffer A with urea-washed ROS membranes (33 µM Rh) or membranes plus 100 µM GDP S in
the dark or light for 10 min. The samples were centrifuged, and the
pellets were resuspended in buffer A containing 25% glycerol to a
final volume of 0.34 ml. Digestion with TPCK-treated trypsin was
carried out as described under "Experimental Procedures." As
control, Gt (0.54 mg) in solution was similarly treated
with TPCK-treated trypsin. At the indicated time points, aliquots were
removed from the incubation mixtures, and the reaction was stopped by
adding TLCK to a final concentration of 40 µg/ml. The proteolytic
fragments (~9 µg of Gt/lane) were separated by electrophoresis on SDS-polyacrylamide gels (12.5%) that were stained with Coomassie Blue. A, time course of Gt
limited tryptic digestion; B, time course of Gt
limited tryptic digestion in the presence of Rh*; C, time
course of Gt limited tryptic digestion in the presence of
Rh* plus GDP S; D, time course of Gt limited
tryptic digestion in the presence of Rh. Molecular weight standards are indicated, as are the size and the origin of the fragments.
Gt, control at time 0.
[View Larger Version of this Image (62K GIF file)]
In the presence of urea-washed ROS membranes, the fragments originating
from the cleavage of the t subunit were visible in the
gels (Fig. 2). Although under all three conditions a small amount of
23 and 14 fragments was present during
the time course, it appeared that there was less of each fragment
throughout the time course (Fig. 2). This was different from the
digestion time course of soluble Gt, in which the two
fragments were generated immediately. Thus, it would appear that the
presence of membranes of any kind partially protects the
t subunit from tryptic cleavage at
Arg129.
To examine the presence of t fragments more clearly,
immunoblotting with antipeptide antibodies of defined specificity was carried out. The anti- t-(195-206) antiserum 8645 recognized several t fragments, which were easily
identifiable in the immunoblot (Fig. 3A),
38, 34, 32,
23, and 21. In the presence of Rh*, the
t subunit was a very poor substrate for tryptic cleavage (Fig. 3B). The 34 and 32
fragments were not generated, while low amounts of 23
and 21 appeared very late in the time course. Similar
experiments performed with monoclonal antibody 4A, which binds to the
amino-terminal region of the t subunit (29); antiserum 1398, which binds to the phosphate binding loop (34); and antiserum 116, which binds to the carboxyl-terminal region (35) confirmed that
under conditions of high affinity interaction between Gt and Rh*, the three major tryptic sites on the t subunit
were protected from cleavage (data not shown).
Fig. 3.
Identification of t
proteolytic fragments by immunoblot using
anti- t-(195-206) antiserum. Purified bovine
Gt (0.55 mg) was incubated in 1 ml of buffer A with PL or
urea-washed ROS membranes (36 µM Rh) in the dark or light
for 10 min. The samples were centrifuged, and the pellets were
resuspended in buffer A containing 25% glycerol to a final volume of
0.34 ml. Digestion with TPCK-treated trypsin was carried out as
described under "Experimental Procedures." As control,
Gt (0.54 mg) in solution was also treated with TPCK-treated
trypsin. At the indicated time points, aliquots were removed from the
incubation mixtures, and the reaction was stopped by adding TLCK to a
final concentration of 40 µg/ml. The proteolytic fragments (~9 µg
of Gt/lane) were separated by electrophoresis on
SDS-polyacrylamide gels (12.5%) and blotted onto nitrocellulose. Antibody binding to t subunit and fragments was detected
as described under "Experimental Procedures." A, time
course of t limited tryptic digestion; B,
time course of t limited tryptic digestion in the
presence of Rh*; C, time course of t limited
tryptic digestion in the presence of PL; D, time course of
t limited tryptic digestion in the presence of Rh.
Molecular weight standards are indicated, as are the size and origin of
the fragments. Gt, control at time 0.
[View Larger Version of this Image (65K GIF file)]
In the presence of ROS membranes that had not been light-activated,
(Fig. 3D) or phospholipid vesicles (Fig. 3C), the
time courses of limited tryptic digestion of the t
subunit were more similar to that obtained in the absence of membranes.
However, the relative production of 32 was lower in the
presence of membranes or PL, probably due to protection of the cleavage
site at Lys18. In addition, in the presence of Rh less
34 was produced, suggesting a modest protection of
Arg310, and the 23 fragment was somewhat
stabilized.
To quantitate the data, we analyzed the immunoblots by densitometry
(Fig. 4). Both the disappearance of t and
the appearance of the 34, 32, and
21 fragments were measured. Fig. 4 shows clearly that
the t subunit was protected in the presence of Rh*. This
implies that all three major proteolytic sites of t are protected when Gt is in high affinity interaction with Rh*
(Table I).
Fig. 4.
Quantitative analysis of t
subunit and proteolytic fragments detected using
anti- t-(195-206) antiserum. The density of the
polypeptide bands was measured using a Molecular Dynamics densitometer.
Each data point is expressed as the integrated area of the polypeptide
band divided by the combined integrated areas of all bands present in
the sample. Time courses of Gt ( ), Gt + Rh*
( ), Gt + Rh* + GDP S ( ), Gt + Rh ( ),
and Gt + PL ( ) limited tryptic digestion are shown. The
presented results are the averages of two experiments. A,
digestion rate of the t subunit; B,
production rate of the 34 fragment; C,
production rate of the 32 fragment; D,
production rate of the 21 fragment.
[View Larger Version of this Image (22K GIF file)]
In the presence of PL, there was an increased generation of
34 (Fig. 4B) and decreased generation of the
32 fragment (Fig. 4C). This suggests that
interaction of Gt with phospholipids leads to protection of
the cleavage site at Lys18 (see also Fig.
5). In the presence of Rh, there was also a decreased production of the 32 fragment (Fig. 4C) but
no compensating increase of 34 (Fig. 4B). In
fact, there was a decreased production of the 34
fragment. This suggests that Rh is capable of weakly protecting the
cleavage site at Arg310. In the presence of either PL or
Rh, the production of 21 was increased with respect to
Gt in solution (Fig. 4D). It thus appears that
proteolytic cleavage at Arg204 is accelerated when
Lys18 is protected.
Fig. 5.
Quantitative analysis of the
38 fragment produced during limited tryptic digestion of
Gt in the presence and absence of phospholipid
vesicles. Incubation of Gt with PL and proteolytic digestion with TPCK-treated trypsin were carried out as described under
"Experimental Procedures." The proteolytic fragments were separated
by electrophoresis on SDS-polyacrylamide gels (12.5%) that were
stained with Coomassie Blue. The density of the stained bands was
measured using a Molecular Dynamics densitometer. Each data point is
expressed as the integrated area of the 38 band divided
by the combined integrated areas of all bands present in the sample.
Time courses of Gt ( ) and Gt + PL ( )
limited tryptic digestion are shown. The production rate of the
38 fragment is shown. Coomassie Blue-stained gels are
shown in the inset: time courses of Gt
(A), and Gt + PL (B) limited tryptic
digestion. Gt, control at time 0.
[View Larger Version of this Image (30K GIF file)]
GDP S is known to reverse the high affinity state between
Gt and Rh* (26, 27). The data (Fig. 4, Table I) show that
the high affinity interaction with Rh* was needed for its protection of
proteolytic sites on t, because there was a partial
reversal of the protection of Arg310 and
Arg204. Comparison of the amounts of 34 and
32 shows that even in the low affinity state, the
cleavage site at Lys18 was protected, consistent with the
ability of PL or Rh to protect this site.
To examine in more detail the ability of phospholipids to protect the
cleavage site at Lys18, we studied the appearance of the
transient 38 fragment in the presence or absence of PL.
Fig. 5 shows that PL completely inhibited the production of the
38 fragment. In addition, in the presence of PL, the
formation of 32 was decreased at the expense of an increased formation of the 34 fragment.
Table I summarizes the findings, while the locations of the various
cleavage sites on the Gt heterotrimer are shown in the stereoview in Fig. 6. It is interesting to note that all
t tryptic cleavage sites are located on the same side of
the molecule (Fig. 6), in close proximity to the receptor,
 t subunit, and effector binding regions. This
observation may suggest that protein regions that are involved in
protein-protein interaction are flexible.
Fig. 6.
Stereo view of heterotrimeric Gt
showing the tryptic cleavage sites on t and
t. The dark spheres denote residues that
are available sites for tryptic hydrolysis.
[View Larger Version of this Image (38K GIF file)]
DISCUSSION
The studies described here provide insight into the regions of a G
protein that bind to an activated receptor. The accessibility of
Gt to tryptic proteolysis is changed dramatically when it
is in high affinity interaction with Rh*. We have dissected the effects of phospholipids, ROS membranes containing inactive Rh, and the low
affinity interaction of GDP S-bound Gt with Rh* on the
availability of the tryptic cleavage sites.
It is well known that heterotrimeric G proteins are membrane-associated
even in the absence of activated receptors. This association is thought
to be mediated mainly by interactions of fatty acyl and prenyl groups
of and subunits with membranes (42, 43). All G protein subunits are modified at or near their amino termini by covalent
attachment of the fatty acid myristate and/or palmitate, while the subunits are prenylated at a cysteine residue located in their carboxyl
termini (43). The t subunit is heterogenously modified
at its amino terminus by myristate and three other less hydrophobic
fatty acids (44, 45), but it does not contain palmitate. The presence
of membranes is important for t- t
subunit interaction (46), so it might be expected that their presence affects the proteolytic cleavage pattern of Gt. In fact, we
found that both phospholipid vesicles and ROS membranes protect the cleavage site in the amino terminus of t at
Lys18.
Numerous biochemical (29, 31, 47, 48) and mutational (49, 50) studies
have implicated the amino terminus of G protein subunits in the
interaction with  subunits. The resolution of the crystal
structure of heterotrimeric Gt (14) has confirmed that the
amino-terminal helix of the t subunit is involved in forming a binding site for the t subunit. Numerous
potential proteolytic cleavage sites are located in this amino-terminal helix of t (29). Navon and Fung (31) have shown that the presence of  t reduces the cleavage rate of the
t subunit at Glu21 by Staphylococcus
aureus V8 protease. The chymotryptic cleavage sites at
Leu15 and Leu19 are partially protected (51) by
the presence of  t that directly contacts these
residues (14). It is likely that in the heterotrimeric Gt
the tryptic cleavage site at Lys18 is also partially
protected. The presence of membranes of any kind determines an increase
of the protection. The effect may be direct or the consequence of a
conformational change of the amino-terminal -helix of
t induced by the concomitant interaction with
 t and membranes. Overall, the protection suggests
that this region is in contact with the membrane, consistent with the crystal structure of the heterotrimer (14).
Our results indicate that in the presence of Rh* the t
subunit of heterotrimeric Gt is almost completely protected
from tryptic hydrolysis. In particular, the cleavage site at
Arg310 is not available for digestion. We cannot determine
whether this protection is the consequence of Rh* binding to that
region of t or a change of t conformation
upon Rh* binding. However, the former possibility is in agreement with
previous observations. Data reported by Hamm et al. (4)
indicate that the t residues 311-323 participate with
the carboxyl-terminal residues 340-350 to form the binding site for
Rh*. Resolution of the crystal structure of the t
subunit in the GTP S and GDP-bound forms (8, 11) has shown that
t residues 320-323 (TCAT) contribute directly to
nucleoside binding through a van der Waals contact with the guanine
ring. A receptor-stimulated movement of -helix 5 may allow for the
release of GDP. Consistent with this suggestion, disturbing the
interactions between the conserved TCAT region ( 6- 5 loop) of the
subunit and the guanine ring of GDP has been shown to decrease GDP
affinity (16, 17). The crystal structures of t-GDP and
heterotrimeric Gt also show that Arg310 is
located in a surface-exposed loop, the 4/ 6 region, which is
spatially close to the carboxyl-terminal residues, 340-350 (Fig. 6).
The activated receptor could trigger the release of bound guanine
nucleotide by interacting with this region in concert with the
COOH-terminal region. Binding of GDP S interacting through the
guanine ring with the 6- 5 loop could decrease the affinity of
the t subunit for Rh* via 6 or 5. This effect is
demonstrated here by the partial reversal of the protective effect of
Rh* at Arg310 by GDP S (Table I). Both guanine nucleoside
diphosphate and triphosphate are able to modulate the interaction of
the t subunit with Rh* and cause Rh* decay as reported
by several observations (26, 27). The mechanism of this communication
between the Rh* and nucleotide binding sites is not known.
In the presence of dark-adapted rhodopsin, the t
cleavage site at Arg310 is not completely available for
tryptic digestion as indicated by the production of lower amounts of
the 34-kDa fragment. A larger amount of the fragment is generated when
Gt is digested in the presence of phospholipid vesicles.
These observations suggest that there is a low affinity interaction of
this region with inactive Rh.
Our data also indicate that in the presence of Rh* another tryptic
cleavage site of t, Arg204, is less
available to digestion. In the presence of GDP S, the accessibility
to this cleavage site is partially restored. Arg204 is
located in the switch II region, residues 198-215 (8), and is
protected from tryptic hydrolysis in the t·GTP S
complex but not in the t·GDP complex (28). The switch
II region undergoes a distinct transition from a distorted helical
structure with the Arg204 side chain in a solvent-exposed
conformation when t is in the GDP-bound form to a well
ordered helix ( 2-helix) interacting with residues from the
3-helix and switch III in the t·GTP S complex
(9). Structural studies have shown that this region forms an important
part of the  t contact interface (14) (Fig. 6). In the
presence of Rh*, protection of the cleavage site of t at
Arg204 can result from a direct interaction of Rh* with
this region or as a consequence of a conformational change induced by
the activated receptor. Alternatively, Rh* can directly or indirectly cooperate with  t to determine this protection. In the
presence of GDP S, this protective effect is reduced. Thus, after
release of GDP as a consequence of t activation by Rh*,
the binding affinity of the switch II region for  t
may increase, and the accessibility of the protease to
Arg204 is almost completely blocked. Our results suggest
that in the "empty pocket" state the t subunit forms
a tight complex with  t and Rh*.
In conclusion, using limited tryptic digestion as an experimental
approach, we have defined the regions of Gt involved in the
interaction with the activated receptor. In the presence of Rh*, two
major cleavage sites of the t subunit,
Arg204 and Arg310, are protected, while the
cleavage rate at Lys18 is substantially decreased in the
presence of either ROS membranes or PL.
FOOTNOTES
*
This work was supported by Grant EY 06062 from the National
Institutes of Health (to H. E. H.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a traveling grant from Council for International
Exchange of Scholars under the Fulbright Program, and a Human Capital x
Mobility grant from the European Community.
To whom correspondence should be addressed: Dept. of
Physiology and Biophysics, University of Illinois at Chicago, 835 S. Wolcott, M/C 901, Chicago, IL 60612. Tel.: 312-996-7272; Fax: 312-996-1414.
1
The abbreviations used are: GTP S, guanosine
5 -O-(thiotriphosphate); Gt, the G protein of
rod outer segment, transducin; Gi1, a G protein coupled to
the inhibition of adenylyl cyclase; Go, a G protein present
predominantly in brain; t and  t, the and  subunits of transducin; o, the subunit of Go; ROS, rod outer segment; Rh, rhodopsin; Rh*,
metarhodopsin II; PL, phospholipid vesicles; PC, phosphatidylcholine;
GDP S, guanyl-5 -yl thiophosphate; PBS, phosphate-buffered saline;
TLCK, 1-chloro-3-tosylamido-7-amino-2-heptanone hydrochloride; TPCK,
L-1-tosylamido-2-phenylethyl chloromethyl ketone; MOPS,
3-(N-morpholino)propanesulfonic acid.
Acknowledgments
We are grateful to Dr. D. Manning for
providing the subunit antisera. We thank Dr. A. Gilchrist, Dr. N. Gill, and Dr. J. Malinski for helpful discussion.
REFERENCES
-
Hargrave, P. A., Hamm, H. E., and Hofmann, K. P.
(1993)
BioEssays
15,
43-50
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hein, L., and Kobilka, B. K.
(1995)
Neuropharmacology
34,
357-366
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Strader, C. D., Fong, T. M., Graziano, M. P., and Tota, M. R.
(1995)
FASEB J.
9,
745-754
[Medline]
[Abstract]
-
Hamm, H. E., Deretic, D., Arendt, A., Hargrave, P. A., Koenig, B., and Hofmann, K. P.
(1988)
Science
241,
832-835
[Medline]
[Abstract/Free Full Text]
-
Conklin, B. R., Farfel, Z., Lusting, K. D., Julius, D., and Bourne, H. R.
(1993)
Nature
363,
274-276
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, C. H., Katz, A., and Simon, M. I.
(1995)
Mol. Pharmacol.
47,
218-223
[Medline]
[Abstract]
-
Rens-Damiano, S., and Hamm, H. E.
(1995)
FASEB J.
9,
1059-1066
[Abstract]
-
Noel, J. P., Hamm, H. E., and Sigler, P. B.
(1993)
Nature
366,
654-663
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sondek, J., Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B.
(1994)
Nature
372,
276-279
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Coleman, D. E., Berghuis, A. M., Lee, E., Linder, M. E., Gilman, A. G., and Sprang, S. R.
(1994)
Science
265,
1405-1412
[Medline]
[Abstract/Free Full Text]
-
Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B.
(1994)
Nature
369,
621-628
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Coleman, D. E., Lee, E., Mixon, M. B., Linder, M. E., Berghuis, A., Gilman, A. G., and Sprang, S. R.
(1994)
J. Mol. Biol.
238,
630-634
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wall, M. A., Coleman, D. E., Lee, E., Iñiguez-Lluhi, J. A., Posner, B. A., Gilman, A. G., and Sprang, S. R.
(1995)
Cell
83,
1047-1058
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B.
(1996)
Nature
379,
311-319
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Denker, B. M., Schmidt, C. J., and Neer, E. J.
(1992)
J. Biol. Chem.
267,
9998-10002
[Medline]
[Abstract/Free Full Text]
-
Garcia, P. D., Onrust, R., Bell, S. M., Sakamar, T. P., and Bourne, H. R.
(1995)
EMBO J.
14,
4460-4469
[Medline]
[Medline]
[Order article via Infotrieve]
-
Thomas, T. C., Schmidt, C. J., and Neer, E. J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10295-10299
[Medline]
[Abstract/Free Full Text]
-
Iyengar, R., Abramowitz, J., Bordelon-Riser, M., Blume, A. J., and Birnbaumer, L.
(1980)
J. Biol. Chem.
255,
10312-10321
[Medline]
[Abstract/Free Full Text]
-
Rojas, F. J., and Birnbaumer, L.
(1985)
J. Biol. Chem.
260,
7829-7835
[Medline]
[Abstract/Free Full Text]
-
Kühn, H.
(1980)
Nature
283,
587-589
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Emeis, D., Kühn, H., Reichert, J., and Hofmann, K. P.
(1982)
FEBS Lett.
143,
29-34
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pfister, C., Kühn, H., and Chabre, M.
(1983)
Eur. J. Biochem.
136,
489-499
[Medline]
[Medline]
[Order article via Infotrieve]
-
Bournaucin, F., Pfister, C., and Chabre, M.
(1989)
Eur. J. Biochem.
184,
687-698
[Medline]
[Order article via Infotrieve]
-
Stryer, L., Hurley, J. B., and Fung, B. K.-K.
(1983)
Methods Enzymol.
96,
617-627
[Medline]
[Medline]
[Order article via Infotrieve]
-
Hamm, H. E.
(1990)
in
The Biology and Medicine of Signal Transduction (Nishizuka, Y., Endo, M., and Tanaka, C., eds), pp. 76-82, Raven Press, New York
-
Kahlert, M., Koning, B., and Hofmann, K. P.
(1990)
J. Biol. Chem.
265,
18928-18932
[Medline]
[Abstract/Free Full Text]
-
Panico, J., Parkes, J. H., and Liebman, P. A.
(1990)
J. Biol. Chem.
265,
18922-18927
[Medline]
[Abstract/Free Full Text]
-
Fung, B. K.-K., and Nash, C. R.
(1983)
J. Biol. Chem.
258,
10503-10510
[Abstract/Free Full Text]
-
Mazzoni, M. R., Malinski, J. A., and Hamm, H. E.
(1991)
J. Biol. Chem.
266,
14072-14081
[Medline]
[Abstract/Free Full Text]
-
Hurley, J. B., Simon, M. L., Teplow, D. B., Robishaw, J. D., and Gilman, A. G.
(1984)
Science
226,
860-862
[Medline]
[Abstract/Free Full Text]
-
Navon, S. E., and Fung, B. K.-K.
(1987)
J. Biol. Chem.
262,
15746-15751
[Medline]
[Abstract/Free Full Text]
-
Hamm, H. E., and Bownds, M. D.
(1984)
J. Gen. Physiol.
84,
265-280
[Medline]
[Abstract/Free Full Text]
-
Witt, P. L., Hamm, H. E., and Bownds, M. D.
(1984)
J. Gen. Physiol.
84,
251-263
[Medline]
[Abstract/Free Full Text]
-
Carlson, K. E., Brass, L. F., and Manning, D. R.
(1989)
J. Biol. Chem.
264,
13298-13305
[Medline]
[Abstract/Free Full Text]
-
Skiba, N. P., Bae, H., and Hamm, H. E.
(1996)
J. Biol. Chem.
271,
413-424
[JBC][Medline]
[Abstract/Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Towbin, H., Staehelin, T., and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
[Medline]
[Abstract/Free Full Text]
-
Kim, J., Blackshear, P. J., Johnson, J. D., and McLaughlin, S.
(1994)
Biophys. J.
67,
227-237
[Medline]
[Medline]
[Order article via Infotrieve]
-
Malinski, J. A., and Wensel, T. G.
(1992)
Biochemistry
31,
9502-9512
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamanaka, G., Eckstein, F., and Stryer, L.
(1985)
Biochemistry
24,
8094-8101
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamane, H. K., and Fung, B. K.-K.
(1993)
Annu. Rev. Pharmacol. Toxicol.
32,
201-241
[CrossRef]
-
Wedegaertner, P. B., Wilson, P. T., and Bourne, H. R.
(1995)
J. Biol. Chem.
270,
503-506
[JBC][Medline]
[Free Full Text]
-
Kokame, K., Fukada, Y., Yoshizawa, T., Takao, T., and Shimonishi, Y.
(1992)
Nature
359,
749-752
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Neubert, T. A., Johnson, R. S., Hurley, J. B., and Walsh, K. A.
(1992)
J. Biol. Chem.
267,
18274-18277
[Medline]
[Abstract/Free Full Text]
-
Bigay, J., Faurobert, E., Franco, M., and Chabre, M.
(1994)
Biochemistry
33,
14081-14090
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mazzoni, M. R., and Hamm, H. E.
(1989)
Biochemistry
28,
9873-9880
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
-
Neer, E. J., Pulsifer, L., and Wolf, L. G.
(1988)
J. Biol. Chem.
263,
8996-9000
[Medline]
[Abstract/Free Full Text]
-
Graf, R., Mattera, R., Codina, J., Estes, M. K., and Birnbaumer, L.
(1992)
J. Biol. Chem.
267,
24307-24314
[Medline]
[Abstract/Free Full Text]
-
Denker, B. M., Neer, E. J., and Schmidt, C. J.
(1992)
J. Biol. Chem.
267,
6272-6277
[Medline]
[Abstract/Free Full Text]
-
Mazzoni, M. R., and Hamm, H. E.
(1993)
J. Protein Chem.
12,
215-221
[Medline]
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Heydorn, R. J. Ward, R. Jorgensen, M. M. Rosenkilde, T. M. Frimurer, G. Milligan, and E. Kostenis
Identification of a Novel Site within G Protein {alpha} Subunits Important for Specificity of Receptor-G Protein Interaction
Mol. Pharmacol.,
August 1, 2004;
66(2):
250 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Cabrera-Vera, J. Vanhauwe, T. O. Thomas, M. Medkova, A. Preininger, M. R. Mazzoni, and H. E. Hamm
Insights into G Protein Structure, Function, and Regulation
Endocr. Rev.,
December 1, 2003;
24(6):
765 - 781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Havlickova, J. Blahos, I. Brabet, J. Liu, B. Hruskova, L. Prezeau, and J.-P. Pin
The Second Intracellular Loop of Metabotropic Glutamate Receptors Recognizes C Termini of G-protein {alpha}-Subunits
J. Biol. Chem.,
September 12, 2003;
278(37):
35063 - 35070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cai, Y. Itoh, and H. G. Khorana
From the Cover: Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: Use of a photoactivatable reagent
PNAS,
April 24, 2001;
98(9):
4877 - 4882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Mazzoni, S. Taddei, L. Giusti, P. Rovero, C. Galoppini, A. D'Ursi, S. Albrizio, A. Triolo, E. Novellino, G. Greco, et al.
A Galpha s Carboxyl-Terminal Peptide Prevents Gs Activation by the A2A Adenosine Receptor
Mol. Pharmacol.,
July 1, 2000;
58(1):
226 - 236.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Bae, T. M. Cabrera-Vera, K. M. Depree, S. G. Graber, and H. E. Hamm
Two Amino Acids within the alpha 4 Helix of Galpha i1 Mediate Coupling with 5-Hydroxytryptamine1B Receptors
J. Biol. Chem.,
May 21, 1999;
274(21):
14963 - 14971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kitamura, N. Shiraishi, W. D. Singer, M. E. Handlogten, K. Tomita, and R. T. Miller
Endothelin-B receptors activate Galpha 13
Am J Physiol Cell Physiol,
April 1, 1999;
276(4):
C930 - C937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Natochin, A. E. Granovsky, K. G. Muradov, and N. O. Artemyev
Roles of the Transducin alpha -Subunit alpha 4-Helix/alpha 4-beta 6 Loop in the Receptor and Effector Interactions
J. Biol. Chem.,
March 19, 1999;
274(12):
7865 - 7869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gilchrist, M. R. Mazzoni, B. Dineen, A. Dice, J. Linden, W. R. Proctor, C. R. Lupica, T. V. Dunwiddie, and H. E. Hamm
Antagonists of the Receptor-G Protein Interface Block Gi-coupled Signal Transduction
J. Biol. Chem.,
June 12, 1998;
273(24):
14912 - 14919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Hamm
The Many Faces of G Protein Signaling
J. Biol. Chem.,
January 9, 1998;
273(2):
669 - 672.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bae, K. Anderson, L. A. Flood, N. P. Skiba, H. E. Hamm, and S. G. Graber
Molecular Determinants of Selectivity in 5-Hydroxytryptamine1B Receptor-G Protein Interactions
J. Biol. Chem.,
December 19, 1997;
272(51):
32071 - 32077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Aris, A. Gilchrist, S. Rens-Domiano, C. Meyer, P. J. Schatz, E. A. Dratz, and H. E. Hamm
Structural Requirements for the Stabilization of Metarhodopsin II by the C Terminus of the alpha subunit of Transducin
J. Biol. Chem.,
January 19, 2001;
276(4):
2333 - 2339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Blahos, T. Fischer, I. Brabet, D. Stauffer, G. Rovelli, J. Bockaert, and J.-P. Pin
A Novel Site on the Galpha -protein That Recognizes Heptahelical Receptors
J. Biol. Chem.,
January 26, 2001;
276(5):
3262 - 3269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Marin, A. G. Krishna, V. Archambault, E. Simuni, W.-Y. Fu, and T. P. Sakmar
The Function of Interdomain Interactions in Controlling Nucleotide Exchange Rates in Transducin
J. Biol. Chem.,
June 22, 2001;
276(26):
23873 - 23880.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|